Lilly's retatrutide has been offered to a single person via 'compassionate use' program

The “triple-G” weight loss drug, Pfizer’s lung cancer trial results, and more biotech news from The Readout

Darron Cummings/AP

Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected by FDA changes, and the emerging psychedelics drug sector. She co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70.

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Good morning. As you go about your day today, may you have the confidence of Bryan Johnson and the self-awareness of Elizabeth Holmes (or whoever is behind Holmes’ X account).